Suvorexant for Post-Traumatic Stress Disorder
This trial will test whether suvorexant, a drug that reduces orexin, can improve sleep disturbances and PTSD symptoms in Veterans.
- Post Traumatic Stress Disorder
- Sleep Disorders
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA cleared Suvorexant for public use?
"While Phase 4 trials are not as commonly conducted as earlier phases, this treatment has been approved and is considered safe."
Are there any other scientific papers that mention Suvorexant?
"As of this date, there are 14 active clinical trials testing Suvorexant. 2 of these studies have progressed to Phase 3. The primary research site is located in Silver Spring, Maryland; however, 71 other medical centres across the country are also conducting research on Suvorexant."
How many total people are eligible for this research project?
"That is correct, the online clinicaltrials.gov registry shows that this study is open and recruiting patients. This specific trial was posted on 8/30/2019 and updated as recently as 11/10/2022. The research team is looking to enroll a total of 144 patients at 2 different sites."
Will elderly patients be accepted into this clinical trial?
"Enrolment for this study is open to patients that are between 18-75 years of age."
Might I be eligible to join this clinical research?
"This study is actively recruiting participants who are currently experiencing sleeplessness. In order to be eligible, individuals must meet the following criteria: 18-75 years of age, US military service history, able to read and understand English, ability to provide written informed consent, Criterion A event meets DSM-5 criteria, PTSD symptoms >3 months duration as indexed by a CAPS-5 12 and a partial PTSD diagnosis at screening, Insomnia indicated by an ISI score > 14, Sertraline, Paroxetine, Fluoxetine, Fluvoxamine, Citalopram or Escitalopram."
Are there any current vacancies for this research project?
"This is an ongoing clinical trial that was originally posted on August 30th, 2019 and has been actively recruiting patients since. The most recent edit occurred on November 10th, 2020."